Navigation Links
Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available Online
Date:5/3/2013

BETHESDA, Md., May 3, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today the availability on the web of several interviews of their CEO Linda Powers on the floor of the New York Stock Exchange on May 1, 2013 by FOX Business News (FOX), the Huffington Post, and the International Business Times, amongst others.

(Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO)

In the FOX interview, Ms. Powers described the importance of NW Bio's DCVax technology in mobilizing a patient's whole immune system, and in targeting the full set of biomarkers on the cancer. This way, the DCVax treatment involves many active agents hitting many targets on the cancer, rather than just a single active agent hitting a single target, as is typical with cancer drugs and some other types of immune therapies. Ms. Powers explained that NW Bio's approach makes it harder for the tumor to "escape," which the Company believes is responsible for the striking results in clinical trials so far, adding years of survival in patients (rather than weeks or months) and doing so without toxicity. These results are clearly differentiating NW Bio from other players in this burgeoning field.

You can see the FOX interview at http://video.foxbusiness.com/v/2344168115001/latest-advances-in-cancer-research/

In the Huffington Post and New York Financial Press interview, Ms. Powers outlined in more detail the process for combining the tumor tissue biomarkers with the dendritic cells (master immune cells), obtained
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
2. Griffin Securities Analyst Interviews Unilife Corp. CEO in a Two-Part Video Series
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
6. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
7. BioSurplus Expands, Debuts New 8000 Square Foot Warehouse and Service Facility
8. Neurocrine Biosciences Reports First Quarter 2012 Results
9. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
10. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
11. BioSurplus Announces Launch of Depot Service for Agilent and AKTA HPLCs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... publication of the results of the Company,s 72-patient, ... eye drops) for the treatment of dry eye ... ® ) model.  The exploratory study was completed ... previously disseminated by the Company in a press ...
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
(Date:5/22/2015)... 22, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... systems ("EPS"), today announced that its CGuard TM Embolic ... investigator Prof. Piotr Musialek , at the EuroPCR ... France . PARADIGM, an investigator-initiated P ... A roti D revascularization I n symptomatic and ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Property portfolio of TIGR® Matrix Surgical ... of a second U.S. patent related to material degradation ... based on the hypothesis that soft tissue positively remodels ... – a process known as ,mechanotransduction, which is the ...
... 27, 2011  Perrigo Company (Nasdaq: PRGO;TASE) today announced that ... and Drug Administration for its abbreviated new drug application ... sued for patent infringement based upon its filing of ... the case in 2008. Under the terms of the ...
Cached Medicine Technology:Novus Scientific Announces a New U.S. Patent for a Mesh Implant Comprising Two Different Resorbable Materials with Different Degradation Times and Specific Mechanical Behaviours; U.S. Patent No. -- 8,083,755 2Perrigo Announces FDA Final Approval for Desloratadine 2
(Date:5/23/2015)... Injury lawyer Steven H. Heisler commented today on ... Maryland legislature but which has not been signed to date ... HB 449 with overwhelming bipartisan support on April 10, ... law. This bill ensures that fracking is prohibited in Maryland ... danger of fracking to our water supplies and the air ...
(Date:5/22/2015)... Liverpool, OH (PRWEB) May 22, 2015 ... announced that Kyle Johnson, the health system’s Chief Financial ... other interests. Johnson has served as the company CFO ... Wesley West will be joining the health system as ... on an interim basis, while the Board of Trustees ...
(Date:5/22/2015)... Commack, Long Island, NY (PRWEB) May 22, 2015 ... Spa announces that June 17, 2015, the Annual ... will take place. Since 2007, Hands On HCMT offers drastically ... the massage therapists and estheticians have enough sessions, through what ... summer. And, it is wonderful for the community as well. ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning of vacation ... to help promote safe travel. , According to estimates from ... this Memorial Day weekend. Amica is sharing the following road ... , , Always wear a seatbelt: Make ... they’re driving or riding along as a passenger. Seatbelts are ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
Breaking Medicine News(10 mins):Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 2Health News:Baltimore Attorney Urges Governor Hogan to Sign the Fracking Moratorium Bill 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2
... ... Frontiers, UCF Comprehensive Compliance Database will Allow Organizations to Gain Greater Risk Visibility, Simplify ... ... ®, the global leader in operational endpoint security , has partnered with ...
... Scratches Surface in Terms of Meeting Seniors, Realistic Needs , ... the 2009 session of the Texas Legislature prior to the ... the Texas Health Care Association (THCA) said that while thankful ... for Medicaid-financed nursing home care, substantially more investment is required ...
... ... on eye care and safety. , ... Minneapolis, MN (PRWEB) June 29, 2009 -- Stop squinting…proper eye care and safety can ... all their brilliance and clarity., , , The Healthcare Scoop , in recognition of National ...
... , Complimentary Continuing Education Monograph for Healthcare Professionals , ... (HAE) is an autosomal dominant disease affecting between 4,000 ... recurrent attacks of intense localized edema involving the skin, ... androgens or plasmin inhibitors has been the mainstay of ...
... by manipulating important immune system cells. This is shown ... University of Gothenburg, Sweden. The discovery may lead to ... About half of the world,s population carries Helicobacter ... never experience any symptoms, but around 10% get peptic ...
... Md., June 29, 2009 As Viet Nam,s industrial ... have recognized the importance of helping to secure the ... this need, the Vietnamese Pharmacopoeia Commission (VPC) has signed ... (USP) Convention. USP is a scientific nonprofit organization that ...
Cached Medicine News:Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 2Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 3Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 4Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 5Health News:Lumension Integrates With Network Frontiers' Unified Compliance Framework To Simplify Compliance Challenges, Reduce Costs, And Harmonize Controls 6Health News:THCA on 2009 Legislative Session: Seniors' Medicaid-Financed Nursing Home Care Requires Substantially More Investment as Population Ages, Care Needs Grow 2Health News:The Healthcare Scoop Community Says 'Eye Care' 2Health News:The Healthcare Scoop Community Says 'Eye Care' 3Health News:Changing Paradigms in Hereditary Angioedema: Pathophysiology, Diagnosis and Treatment 2Health News:Vietnamese drug authority teams with United States standards-setting organization 2
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: